Drug ID: | NPD7447 |
Drug Name: | CHF-4227 |
Molecular Formula: | C30H33NO4 |
Canonical SMILES: | COc1ccc(cc1)C1=C(Cc2ccc(cc2)OCCN2CCCCC2)c2c(OC1)cc(cc2)O |
Standard InCHI: | InChI=1S/C30H33NO4/c1-33-25-12-7-23(8-13-25)29-21-35-30-20-24(32)9-14-27(30)28(29)19-22-5-10-26(11-6-22)34-18-17-31-15-3-2-4-16-31/h5-14,20,32H,2-4,15-19,21H2,1H3 |
Standard InCHIKey: | ZUDXUNPSRMREOJ-UHFFFAOYSA-N |
Max Developmental Stage: | Phase 1 |
Max Developmental Stage Source: | ChEMBL |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB012797 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 471.24 |
ALogP | -1.0803 |
MLogP | 4.21 |
XLogP | 5.805 |
HDA | 1 |
HBD | 1 |
Rotatable Bonds | 10 |
TPSA | 51.16 |
RO5 Violation | 1 |